If you are wondering whether Natera's share price still lines up with its fundamentals, you are not alone. This article focuses squarely on what the current valuation might mean for you. Natera's ...

In January 2026, Corvus Pharmaceuticals reported past positive Phase 1 data from cohort 4 of its placebo-controlled trial of soquelitinib for moderate to severe atopic dermatitis, and moved ahead with ...